PCRX — Pacira BioSciences, Inc. stock price, charts and financials

QT53Pacira BioSciences, Inc.

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
24.30
-0.72-2.88%
PCRXQT53Pacira BioSciences, Inc.·NASDAQ
24.30-2.88%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 04, 2026S-8Registration of employee benefit securities
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jun 30, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20263Initial statement of beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 2026DEFA14AAdditional proxy soliciting materials
Jun 01, 2026DEFA14AAdditional proxy soliciting materials
May 28, 2026DEFA14AAdditional proxy soliciting materials
May 28, 2026DFAN14ADFAN14A
May 27, 2026DEFA14AAdditional proxy soliciting materials
May 26, 2026DEFA14AAdditional proxy soliciting materials